Global Antiandrogen Monotherapy Sales Market Report Forecast 2017-2022

July 2017 | 102 pages | ID: G2492DA6B28EN
S&P Consulting

Abstracts

Delivery of the Report will take 2-3 working days once order is placed.

The report offers a comprehensive evaluation of the market. It does so via in-depth insights, understanding market evolution by tracking historical developments, and analyzing the present scenario and future projections based on optimistic and likely scenarios. Each research report serves as a repository of analysis and information for every facet of the market, including but not limited to: Regional markets, technology developments, types, applications, and the competitive landscape.

The study is a source of reliable data on:

• Key market segments and sub-segments
• Evolving market trends and dynamics
• Changing supply and demand scenarios
• Quantifying market opportunities through market sizing and market forecasting
• Tracking current trends/opportunities/challenges
• Competitive insights
• Opportunity mapping in terms of technological breakthroughs

This research report analyzes this market on the basis of its market segments, major geographies, and current market trends. Geographies analyzed under this research report include:
United States
China
Europe
Japan

The Major players reported in the market include:

Pfizer Inc. (USA)
Abbott Laboratories (USA)
Genentech Inc. (USA)
GlaxoSmithKline Plc (UK)
Immunomedics, Inc. (USA)
Indevus Pharmaceuticals Inc. (USA)
Novartis AG (Switzerland)
OSI Pharmaceuticals, Inc. (USA)
Paladin Labs Inc. (Canada)

Product Segment Analysis:

• Type 1
• Type 2
• Type 3

Application Segment Analysis:

• Application 1
• Application 2
• Application 3

Reasons for Buying this Report

• This report provides pin-point analysis for changing competitive dynamics
• It provides a forward looking perspective on different factors driving or restraining market growth
• It provides a six-year forecast assessed on the basis of how the market is predicted to grow
• It helps in understanding the key product segments and their future
• It provides pin point analysis of changing competition dynamics and keeps you ahead of competitors
• It helps in making informed business decisions by having complete insights of market and by making in-depth analysis of market segments
• It provides distinctive graphics and exemplified analysis of major market segments

Contents

1 ANTIANDROGEN MONOTHERAPY MARKET OVERVIEW

1.1 Product Overview and Scope of Antiandrogen Monotherapy
1.2 Classification of Antiandrogen Monotherapy
  1.2.1 Type
  1.2.2 Type
  1.2.3 Type
1.3 Application of Antiandrogen Monotherapy
  1.3.2 Application
  1.3.3 Application
  1.3.4 Application
1.4 Antiandrogen Monotherapy Market States Status and Prospect (2012-2022) by Regions
  1.4.1 United States
  1.4.2 China
  1.4.3 Europe
  1.4.4 Japan
1.5 Global Market Size of Antiandrogen Monotherapy (2012-2022)
  1.5.1 Global Antiandrogen Monotherapy Sales and Growth Rate (2012-2022)
  1.5.2 Global Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)

2 GLOBAL ECONOMIC IMPACT ON ANTIANDROGEN MONOTHERAPY INDUSTRY

2.1 Global Macroeconomic Environment Analysis
  2.1.1 Global Macroeconomic Analysis
  2.1.2 Global Macroeconomic Environment Development Trend
2.2 Global Macroeconomic Environment Analysis by Regions

3 ANTIANDROGEN MONOTHERAPY MANUFACTURING COST ANALYSIS

3.1 Antiandrogen Monotherapy Key Raw Materials Analysis
  3.1.1 Key Raw Materials
  3.1.2 Price Trend of Key Raw Materials
  3.1.3 Key Suppliers of Raw Materials
  3.1.4 Market Concentration Rate of Raw Materials
3.2 Proportion of Manufacturing Cost Structure
  3.2.1 Raw Materials
  3.2.2 Labor Cost
  3.2.3 Manufacturing Process Analysis of Antiandrogen Monotherapy

4 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

4.1 Antiandrogen Monotherapy Industrial Chain Analysis
4.2 Upstream Raw Materials Sourcing
4.3 Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
4.4 Downstream Buyers

5 GLOBAL ANTIANDROGEN MONOTHERAPY COMPETITION BY MANUFACTURERS, TYPE AND APPLICATION

5.1 Global Antiandrogen Monotherapy Market Competition by Manufacturers
  5.1.1 Global Antiandrogen Monotherapy Sales and Market Share of Key Manufacturers (2012-2017)
  5.1.2 Global Antiandrogen Monotherapy Revenue and Share by Manufacturers (2012-2017)
5.2 Global Antiandrogen Monotherapy (Volume and Value) by Type
  5.5.1 Global Antiandrogen Monotherapy Sales and Market Share by Type (2012-2017)
  5.5.2 Global Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
5.3 Global Antiandrogen Monotherapy (Volume and Value) by Regions
  5.3.1 Global Antiandrogen Monotherapy Sales and Market Share by Regions (2012-2017)
  5.3.2 Global Antiandrogen Monotherapy Revenue and Market Share by Regions (2012-2017)
5.4 Global Antiandrogen Monotherapy (Volume) by Application

6 UNITED STATES ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

6.1 United States Antiandrogen Monotherapy Sales and Value (2012-2017)
  6.1.1 United States Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  6.1.2 United States Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  6.1.3 United States Antiandrogen Monotherapy Sales Price Trend (2012-2017)
6.2 United States Antiandrogen Monotherapy Sales and Market Share by Manufacturers
6.3 United States Antiandrogen Monotherapy Sales and Market Share by Type
6.4 United States Antiandrogen Monotherapy Sales and Market Share by Application

7 CHINA ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

7.1 China Antiandrogen Monotherapy Sales and Value (2012-2017)
  7.1.1 China Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  7.1.2 China Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  7.1.3 China Antiandrogen Monotherapy Sales Price Trend (2012-2017)
7.2 China Antiandrogen Monotherapy Sales and Market Share by Manufacturers
7.3 China Antiandrogen Monotherapy Sales and Market Share by Type
7.4 China Antiandrogen Monotherapy Sales and Market Share by Application

8 EUROPE ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

8.1 Europe Antiandrogen Monotherapy Sales and Value (2012-2017)
  8.1.1 Europe Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  8.1.2 Europe Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  8.1.3 Europe Antiandrogen Monotherapy Sales Price Trend (2012-2017)
8.2 Europe Antiandrogen Monotherapy Sales and Market Share by Manufacturers
8.3 Europe Antiandrogen Monotherapy Sales and Market Share by Type
8.4 Europe Antiandrogen Monotherapy Sales and Market Share by Application

9 JAPAN ANTIANDROGEN MONOTHERAPY (VOLUME, VALUE AND SALES PRICE)

9.1 Japan Antiandrogen Monotherapy Sales and Value (2012-2017)
  9.1.1 Japan Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
  9.1.2 Japan Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
  9.1.3 Japan Antiandrogen Monotherapy Sales Price Trend (2012-2017)
9.2 Japan Antiandrogen Monotherapy Sales and Market Share by Manufacturers
9.3 Japan Antiandrogen Monotherapy Sales and Market Share by Type
9.4 Japan Antiandrogen Monotherapy Sales and Market Share by Application

10 GLOBAL ANTIANDROGEN MONOTHERAPY MANUFACTURERS ANALYSIS

10.1 Pfizer Inc. (USA)
  10.1.1 Company Basic Information, Manufacturing Base and Competitors
  10.1.2 Product Type, Application and Specification
  10.1.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.1.4 Business Overview
10.2 Abbott Laboratories (USA)
  10.2.1 Company Basic Information, Manufacturing Base and Competitors
  10.2.2 Product Type, Application and Specification
  10.2.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.2.4 Business Overview
10.3 Genentech Inc. (USA)
  10.3.1 Company Basic Information, Manufacturing Base and Competitors
  10.3.2 Product Type, Application and Specification
  10.3.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.3.4 Business Overview
10.4 GlaxoSmithKline Plc (UK)
  10.4.1 Company Basic Information, Manufacturing Base and Competitors
  10.4.2 Product Type, Application and Specification
  10.4.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.4.4 Business Overview
10.5 Immunomedics, Inc. (USA)
  10.5.1 Company Basic Information, Manufacturing Base and Competitors
  10.5.2 Product Type, Application and Specification
  10.5.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.5.4 Business Overview
10.6 Indevus Pharmaceuticals Inc. (USA)
  10.6.1 Company Basic Information, Manufacturing Base and Competitors
  10.6.2 Product Type, Application and Specification
  10.6.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.6.4 Business Overview
10.7 Novartis AG (Switzerland)
  10.7.1 Company Basic Information, Manufacturing Base and Competitors
  10.7.2 Product Type, Application and Specification
  10.7.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.7.4 Business Overview
10.8 OSI Pharmaceuticals, Inc. (USA)
  10.8.1 Company Basic Information, Manufacturing Base and Competitors
  10.8.2 Product Type, Application and Specification
  10.8.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.8.4 Business Overview
10.9 Paladin Labs Inc. (Canada)
  10.9.1 Company Basic Information, Manufacturing Base and Competitors
  10.9.2 Product Type, Application and Specification
  10.9.3 Sales, Revenue, Price and Gross Margin (2012-2017)
  10.9.4 Business Overview

...

11 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

11.1 Marketing Channel
  11.1.1 Direct Marketing
  11.1.2 Indirect Marketing
  11.1.3 Marketing Channel Development Trend
11.2 Market Positioning
  11.2.1 Pricing Strategy
  11.2.2 Brand Strategy
  11.2.3 Target Client
11.3 Distributors/Traders List

12 MARKET EFFECT FACTORS ANALYSIS

12.1 Technology Progress/Risk
  12.1.1 Substitutes Threat
  12.1.2 Technology Progress in Related Industry
12.2 Consumer Needs/Customer Preference Change
12.3 Economic/Political Environmental Change

13 GLOBAL ANTIANDROGEN MONOTHERAPY MARKET FORECAST (2017-2022)

13.1 Global Antiandrogen Monotherapy Sales, Revenue Forecast (2017-2022)
13.2 Global Antiandrogen Monotherapy Sales Forecast by Regions (2017-2022)
13.3 Global Antiandrogen Monotherapy Sales Forecast by Type (2017-2022)
13.4 Global Antiandrogen Monotherapy Sales Forecast by Application (2017-2022)

14 APPENDIX

List Of Tables

LIST OF TABLES AND FIGURES

FIGURE PICTURE OF ANTIANDROGEN MONOTHERAPY

Table Classification of Antiandrogen Monotherapy
Figure Global Sales Market Share of Antiandrogen Monotherapy by Type in 2016
Table Applications of Antiandrogen Monotherapy
Figure Global Sales Market Share of Antiandrogen Monotherapy by Application in 2016
Figure United States Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure China Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure Europe Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure Japan Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Figure Global Antiandrogen Monotherapy Sales and Growth Rate (2012-2022)
Figure Global Antiandrogen Monotherapy Revenue and Growth Rate (2012-2022)
Table Global Antiandrogen Monotherapy Sales of Key Manufacturers (2012-2017)
Table Global Antiandrogen Monotherapy Sales Share by Manufacturers (2012-2017)
Figure 2015 Antiandrogen Monotherapy Sales Share by Manufacturers
Figure 2016 Antiandrogen Monotherapy Sales Share by Manufacturers
Table Global Antiandrogen Monotherapy Revenue by Manufacturers (2012-2017)
Table Global Antiandrogen Monotherapy Revenue Share by Manufacturers (2012-2017)
Table 2015 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table 2016 Global Antiandrogen Monotherapy Revenue Share by Manufacturers
Table Global Antiandrogen Monotherapy Sales and Market Share by Type (2012-2017)
Table Global Antiandrogen Monotherapy Sales Share by Type (2012-2017)
Figure Sales Market Share of Antiandrogen Monotherapy by Type (2012-2017)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Type (2012-2017)
Table Global Antiandrogen Monotherapy Revenue and Market Share by Type (2012-2017)
Table Global Antiandrogen Monotherapy Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Antiandrogen Monotherapy by Type (2012-2017)
Figure Global Antiandrogen Monotherapy Revenue Growth Rate by Type (2012-2017)
Table Global Antiandrogen Monotherapy Sales and Market Share by Regions (2012-2017)
Table Global Antiandrogen Monotherapy Sales Share by Regions (2012-2017)
Figure Sales Market Share of Antiandrogen Monotherapy by Regions (2012-2017)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Regions (2012-2017)
Table Global Antiandrogen Monotherapy Revenue and Market Share by Regions (2012-2017)
Table Global Antiandrogen Monotherapy Revenue Share by Regions (2012-2017)
Figure Revenue Market Share of Antiandrogen Monotherapy by Regions (2012-2017)
Figure Global Antiandrogen Monotherapy Revenue Growth Rate by Regions (2012-2017)
Table Global Antiandrogen Monotherapy Sales and Market Share by Application (2012-2017)
Table Global Antiandrogen Monotherapy Sales Share by Application (2012-2017)
Figure Sales Market Share of Antiandrogen Monotherapy by Application (2012-2017)
Figure Global Antiandrogen Monotherapy Sales Growth Rate by Application (2012-2017)
Figure United States Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure United States Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure United States Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table United States Antiandrogen Monotherapy Sales by Manufacturers (2012-2017)
Table United States Antiandrogen Monotherapy Market Share by Manufacturers (2012-2017)
Table United States Antiandrogen Monotherapy Sales by Type (2012-2017)
Table United States Antiandrogen Monotherapy Market Share by Type (2012-2017)
Table United States Antiandrogen Monotherapy Sales by Application (2012-2017)
Table United States Antiandrogen Monotherapy Market Share by Application (2012-2017)
Figure China Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure China Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure China Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table China Antiandrogen Monotherapy Sales by Manufacturers (2012-2017)
Table China Antiandrogen Monotherapy Market Share by Manufacturers (2012-2017)
Table China Antiandrogen Monotherapy Sales by Type (2012-2017)
Table China Antiandrogen Monotherapy Market Share by Type (2012-2017)
Table China Antiandrogen Monotherapy Sales by Application (2012-2017)
Table China Antiandrogen Monotherapy Market Share by Application (2012-2017)
Figure Europe Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure Europe Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure Europe Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table Europe Antiandrogen Monotherapy Sales by Manufacturers (2012-2017)
Table Europe Antiandrogen Monotherapy Market Share by Manufacturers (2012-2017)
Table Europe Antiandrogen Monotherapy Sales by Type (2012-2017)
Table Europe Antiandrogen Monotherapy Market Share by Type (2012-2017)
Table Europe Antiandrogen Monotherapy Sales by Application (2012-2017)
Table Europe Antiandrogen Monotherapy Market Share by Application (2012-2017)
Figure Japan Antiandrogen Monotherapy Sales and Growth Rate (2012-2017)
Figure Japan Antiandrogen Monotherapy Revenue and Growth Rate (2012-2017)
Figure Japan Antiandrogen Monotherapy Sales Price Trend (2012-2017)
Table Japan Antiandrogen Monotherapy Sales by Manufacturers (2012-2017)
Table Japan Antiandrogen Monotherapy Market Share by Manufacturers (2012-2017)
Table Japan Antiandrogen Monotherapy Sales by Type (2012-2017)
Table Japan Antiandrogen Monotherapy Market Share by Type (2012-2017)
Table Japan Antiandrogen Monotherapy Sales by Application (2012-2017)
Table Japan Antiandrogen Monotherapy Market Share by Application (2012-2017)
Table Pfizer Inc. (USA) Basic Information List
Table Pfizer Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Pfizer Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Abbott Laboratories (USA) Basic Information List
Table Abbott Laboratories (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Abbott Laboratories (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Genentech Inc. (USA) Basic Information List
Table Genentech Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Genentech Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table GlaxoSmithKline Plc (UK) Basic Information List
Table GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure GlaxoSmithKline Plc (UK) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Immunomedics, Inc. (USA) Basic Information List
Table Immunomedics, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Immunomedics, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Indevus Pharmaceuticals Inc. (USA) Basic Information List
Table Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Indevus Pharmaceuticals Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Novartis AG (Switzerland) Basic Information List
Table Novartis AG (Switzerland) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Novartis AG (Switzerland) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table OSI Pharmaceuticals, Inc. (USA) Basic Information List
Table OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure OSI Pharmaceuticals, Inc. (USA) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Paladin Labs Inc. (Canada) Basic Information List
Table Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Sales, Revenue, Price and Gross Margin (2012-2017)
Figure Paladin Labs Inc. (Canada) Antiandrogen Monotherapy Global Market Share (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Antiandrogen Monotherapy
Figure Manufacturing Process Analysis of Antiandrogen Monotherapy
Figure Antiandrogen Monotherapy Industrial Chain Analysis
Table Raw Materials Sources of Antiandrogen Monotherapy Major Manufacturers in 2016
Table Major Buyers of Antiandrogen Monotherapy
Table Distributors/Traders List
Figure Global Antiandrogen Monotherapy Sales and Growth Rate Forecast (2017-2022)
Figure Global Antiandrogen Monotherapy Revenue and Growth Rate Forecast (2017-2022)
Table Global Antiandrogen Monotherapy Sales Forecast by Regions (2017-2022)
Table Global Antiandrogen Monotherapy Sales Forecast by Type (2017-2022)
Table Global Antiandrogen Monotherapy Sales Forecast by Application (2017-2022)